Trial · NCT00362232
Participant flow14
How many started, completed or left each group, period by period.
1 to 14 of 14
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Treatment (12 +/- 2 Days) | STARTED | Rivaroxaban 10 mg Once Daily (OD) (Xarelto, BAY59-7939) | 1,584 | |
| Treatment (12 +/- 2 Days) | STARTED | Enoxaparin 30 mg Twice a Day (Bid) | 1,564 | |
| Treatment (12 +/- 2 Days) | Received Treatment | Rivaroxaban 10 mg Once Daily (OD) (Xarelto, BAY59-7939) | 1,526 | |
| Treatment (12 +/- 2 Days) | Received Treatment | Enoxaparin 30 mg Twice a Day (Bid) | 1,508 | |
| Treatment (12 +/- 2 Days) | COMPLETED | Rivaroxaban 10 mg Once Daily (OD) (Xarelto, BAY59-7939) | 1,425 | |
| Treatment (12 +/- 2 Days) | COMPLETED | Enoxaparin 30 mg Twice a Day (Bid) | 1,413 | |
| Treatment (12 +/- 2 Days) | NOT COMPLETED | Rivaroxaban 10 mg Once Daily (OD) (Xarelto, BAY59-7939) | 159 | |
| Treatment (12 +/- 2 Days) | NOT COMPLETED | Enoxaparin 30 mg Twice a Day (Bid) | 151 | |
| Follow-up (30 (+ 5) Days) | STARTED | Rivaroxaban 10 mg Once Daily (OD) (Xarelto, BAY59-7939) | 1,471 | |
| Follow-up (30 (+ 5) Days) | STARTED | Enoxaparin 30 mg Twice a Day (Bid) | 1,455 | |
| Follow-up (30 (+ 5) Days) | COMPLETED | Rivaroxaban 10 mg Once Daily (OD) (Xarelto, BAY59-7939) | 1,433 | |
| Follow-up (30 (+ 5) Days) | COMPLETED | Enoxaparin 30 mg Twice a Day (Bid) | 1,416 | |
| Follow-up (30 (+ 5) Days) | NOT COMPLETED | Rivaroxaban 10 mg Once Daily (OD) (Xarelto, BAY59-7939) | 38 | |
| Follow-up (30 (+ 5) Days) | NOT COMPLETED | Enoxaparin 30 mg Twice a Day (Bid) | 39 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00362232/flow